<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21930871</PMID><DateCompleted><Year>2012</Year><Month>05</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-6596</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>2</Issue><PubDate><Year>2012</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Antimicrobial agents and chemotherapy</Title><ISOAbbreviation>Antimicrob Agents Chemother</ISOAbbreviation></Journal><ArticleTitle>Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus.</ArticleTitle><Pagination><StartPage>647</StartPage><EndPage>657</EndPage><MedlinePgn>647-57</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/AAC.00125-11</ELocationID><Abstract><AbstractText>The aim of this study was to identify the antiviral mechanism of a novel compound, BPR3P0128. From a large-scale screening of a library of small compounds, BPR3P compounds were found to be potent inhibitors of influenza viral replication in Madin-Darby canine kidney (MDCK) cells. BPR3P0128 exhibited inhibitory activity against both influenza A and B viruses. The 50% inhibitory concentrations were in the range of 51 to 190 nM in MDCK cells, as measured by inhibition-of-cytopathic-effect assays. BPR3P0128 appeared to target the viral replication cycle but had no effect on viral adsorption. The inhibition of cap-dependent mRNA transcription by BPR3P0128 was more prominent with a concurrent increase in cap-independent cRNA replication in a primer extension assay, suggesting a role of BPR3P0128 in switching transcription to replication. This reduction in mRNA expression resulted from the BPR3P-mediated inhibition of the cap-dependent endoribonuclease (cap-snatching) activities of nuclear extracts containing the influenza virus polymerase complex. No inhibition of binding of 5' viral RNA to the viral polymerase complex by this compound was detected. BPR3P0128 also effectively inhibited other RNA viruses, such as enterovirus 71 and human rhinovirus, but not DNA viruses, suggesting that BPR3P0128 targets a cellular factor(s) associated with viral PB2 cap-snatching activity. The identification of this factor(s) could help redefine the regulation of viral transcription and replication and thereby provide a potential target for antiviral chemotherapeutics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>John T-A</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli 350, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>Jiann-Yih</ForeName><Initials>JY</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Ta-Jen</ForeName><Initials>TJ</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mei-Ling</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Ming-Sian</ForeName><Initials>MS</Initials></Author><Author ValidYN="Y"><LastName>Hsieh</LastName><ForeName>Chung-Fan</ForeName><Initials>CF</Initials></Author><Author ValidYN="Y"><LastName>Chou</LastName><ForeName>Yao Chieh</ForeName><Initials>YC</Initials></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Wen-Fang</ForeName><Initials>WF</Initials></Author><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Kean Seng</ForeName><Initials>KS</Initials></Author><Author ValidYN="Y"><LastName>Hung</LastName><ForeName>Hui-Chen</ForeName><Initials>HC</Initials></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Ming-Yu</ForeName><Initials>MY</Initials></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Shengkai</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Hsieh</LastName><ForeName>Hsing-Pang</ForeName><Initials>HP</Initials></Author><Author ValidYN="Y"><LastName>Horng</LastName><ForeName>Jim-Tong</ForeName><Initials>JT</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Antimicrob Agents Chemother</MedlineTA><NlmUniqueID>0315061</NlmUniqueID><ISSNLinking>0066-4804</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C572379">BPR3P0128</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C502893">PB2 protein, influenza virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011720">Pyrazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011804">Quinolines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012315">RNA Caps</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="D004720">Endonucleases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003588" MajorTopicYN="N">Cytopathogenic Effect, Viral</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004285" MajorTopicYN="N">Dogs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004720" MajorTopicYN="N">Endonucleases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053122" MajorTopicYN="N">Influenza A Virus, H3N2 Subtype</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009981" MajorTopicYN="N">Influenza B virus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009975" MajorTopicYN="N">Orthomyxoviridae</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011720" MajorTopicYN="N">Pyrazoles</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011804" MajorTopicYN="N">Quinolines</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012315" MajorTopicYN="N">RNA Caps</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014158" MajorTopicYN="N">Transcription, Genetic</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2012</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21930871</ArticleId><ArticleId IdType="pmc">PMC3264257</ArticleId><ArticleId IdType="doi">10.1128/AAC.00125-11</ArticleId><ArticleId IdType="pii">AAC.00125-11</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baba M, et al. 1998. Inhibition of human immunodeficiency virus type 1 replication and cytokine production by fluoroquinoline derivatives. Mol. Pharmacol. 53: 1097&#x2013;1103</Citation><ArticleIdList><ArticleId IdType="pubmed">9614214</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas SK, Boutz PL, Nayak DP. 1998. Influenza virus nucleoprotein interacts with influenza virus polymerase proteins. J. Virol. 72: 5493&#x2013;5501</Citation><ArticleIdList><ArticleId IdType="pmc">PMC110190</ArticleId><ArticleId IdType="pubmed">9621005</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaas D, Patzelt E, Kuechler E. 1982. Identification of the cap binding protein of influenza virus. Nucleic Acids Res. 10: 4803&#x2013;4812</Citation><ArticleIdList><ArticleId IdType="pmc">PMC321130</ArticleId><ArticleId IdType="pubmed">7133998</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulo S, Akarsu H, Ruigrok RW, Baudin F. 2007. Nuclear traffic of influenza virus proteins and ribonucleoprotein complexes. Virus Res. 124: 12&#x2013;21</Citation><ArticleIdList><ArticleId IdType="pubmed">17081640</ArticleId></ArticleIdList></Reference><Reference><Citation>Chase G, et al. 2008. Hsp90 inhibitors reduce influenza virus replication in cell culture. Virology 377: 431&#x2013;439</Citation><ArticleIdList><ArticleId IdType="pubmed">18570972</ArticleId></ArticleIdList></Reference><Reference><Citation>Cianci C, Tiley L, Krystal M. 1995. Differential activation of the influenza virus polymerase via template RNA binding. J. Virol. 69: 3995&#x2013;3999</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189131</ArticleId><ArticleId IdType="pubmed">7769657</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti C, et al. 1996. Inhibition of poliovirus replication by prostaglandins A and J. in human cells. Antimicrob. Agents Chemother. 40: 367&#x2013;372</Citation><ArticleIdList><ArticleId IdType="pmc">PMC163118</ArticleId><ArticleId IdType="pubmed">8834882</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne CB, et al. 2011. Comparative RNAi screening reveals host factors involved in enterovirus infection of polarized endothelial monolayers. Cell Host Microbe 9: 70&#x2013;82</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3048761</ArticleId><ArticleId IdType="pubmed">21238948</ArticleId></ArticleIdList></Reference><Reference><Citation>Das K, Aramini JM, Ma LC, Krug RM, Arnold E. 2010. Structures of influenza A proteins and insights into antiviral drug targets. Nat. Struct. Mol. Biol. 17: 530&#x2013;538</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2957899</ArticleId><ArticleId IdType="pubmed">20383144</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawood FS, et al. 2009. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 360: 2605&#x2013;2615</Citation><ArticleIdList><ArticleId IdType="pubmed">19423869</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias A, et al. 2009. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature 458: 914&#x2013;918</Citation><ArticleIdList><ArticleId IdType="pubmed">19194459</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrhardt C, Ludwig S. 2009. A new player in a deadly game: influenza viruses and the PI3K/Akt signalling pathway. Cell. Microbiol. 11: 863&#x2013;871</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7162392</ArticleId><ArticleId IdType="pubmed">19290913</ArticleId></ArticleIdList></Reference><Reference><Citation>Fechter P, Brownlee GG. 2005. Recognition of mRNA cap structures by viral and cellular proteins. J. Gen. Virol. 86: 1239&#x2013;1249</Citation><ArticleIdList><ArticleId IdType="pubmed">15831934</ArticleId></ArticleIdList></Reference><Reference><Citation>Fechter P, et al. 2003. Two aromatic residues in the PB2 subunit of influenza A RNA polymerase are crucial for cap binding. J. Biol. Chem. 278: 20381&#x2013;20388</Citation><ArticleIdList><ArticleId IdType="pubmed">12646557</ArticleId></ArticleIdList></Reference><Reference><Citation>Fislova T, Thomas B, Graef KM, Fodor E. 2010. Association of the influenza virus RNA polymerase subunit PB2 with the host chaperonin CCT. J. Virol. 84: 8691&#x2013;8699</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2919027</ArticleId><ArticleId IdType="pubmed">20573828</ArticleId></ArticleIdList></Reference><Reference><Citation>Fodor E, et al. 2002. A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs. J. Virol. 76: 8989&#x2013;9001</Citation><ArticleIdList><ArticleId IdType="pmc">PMC136441</ArticleId><ArticleId IdType="pubmed">12186883</ArticleId></ArticleIdList></Reference><Reference><Citation>Fodor E, Pritlove DC, Brownlee GG. 1994. The influenza virus panhandle is involved in the initiation of transcription. J. Virol. 68: 4092&#x2013;4096</Citation><ArticleIdList><ArticleId IdType="pmc">PMC236924</ArticleId><ArticleId IdType="pubmed">8189550</ArticleId></ArticleIdList></Reference><Reference><Citation>Francki RI, Jackson AO. 1972. Immunochemical detection of double-stranded ribonucleic acid in leaves of sugar cane infected with Fiji disease virus. Virology 48: 275&#x2013;277</Citation><ArticleIdList><ArticleId IdType="pubmed">4622773</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuta Y, et al. 2009. T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections. Antiviral Res. 82: 95&#x2013;102</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7127082</ArticleId><ArticleId IdType="pubmed">19428599</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastaminza P, Perales B, Falcon AM, Ortin J. 2003. Mutations in the N-terminal region of influenza virus PB2 protein affect virus RNA replication but not transcription. J. Virol. 77: 5098&#x2013;5108</Citation><ArticleIdList><ArticleId IdType="pmc">PMC153989</ArticleId><ArticleId IdType="pubmed">12692212</ArticleId></ArticleIdList></Reference><Reference><Citation>Geller R, Vignuzzi M, Andino R, Frydman J. 2007. Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance. Genes Dev. 21: 195&#x2013;205</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1770902</ArticleId><ArticleId IdType="pubmed">17234885</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilligay D, et al. 2008. The structural basis for cap binding by influenza virus polymerase subunit PB2. Nat. Struct. Mol. Biol. 15: 500&#x2013;5066</Citation><ArticleIdList><ArticleId IdType="pubmed">18454157</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara K, Schmidt FI, Crow M, Brownlee GG. 2006. Amino acid residues in the N-terminal region of the PA subunit of influenza A virus RNA polymerase play a critical role in protein stability, endonuclease activity, cap binding, and virion RNA promoter binding. J. Virol. 80: 7789&#x2013;7798</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1563815</ArticleId><ArticleId IdType="pubmed">16873236</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatada E, Hasegawa M, Mukaigawa J, Shimizu K, Fukuda R. 1989. Control of influenza virus gene expression: quantitative analysis of each viral RNA species in infected cells. J. Biochem. 105: 537&#x2013;546</Citation><ArticleIdList><ArticleId IdType="pubmed">2760014</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson B. 2010. Integrating the cell stress response: a new view of molecular chaperones as immunological and physiological homeostatic regulators. Cell Biochem. Funct. 28: 1&#x2013;14</Citation><ArticleIdList><ArticleId IdType="pubmed">19830685</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirayama E, Atagi H, Hiraki A, Kim J. 2004. Heat shock protein 70 is related to thermal inhibition of nuclear export of the influenza virus ribonucleoprotein complex. J. Virol. 78: 1263&#x2013;1270</Citation><ArticleIdList><ArticleId IdType="pmc">PMC321380</ArticleId><ArticleId IdType="pubmed">14722281</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann HH, Kunz A, Simon VA, Palese P, Shaw ML. 2011. Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis. Proc. Natl. Acad. Sci. U. S. A. 108: 5777&#x2013;5782</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3078400</ArticleId><ArticleId IdType="pubmed">21436031</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh HP, Hsu JT. 2007. Strategies of development of antiviral agents directed against influenza virus replication. Curr. Pharm. Des. 13: 3531&#x2013;3542</Citation><ArticleIdList><ArticleId IdType="pubmed">18220789</ArticleId></ArticleIdList></Reference><Reference><Citation>Huarte M, et al. 2003. Threonine 157 of influenza virus PA polymerase subunit modulates RNA replication in infectious viruses. J. Virol. 77: 6007&#x2013;6013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC154019</ArticleId><ArticleId IdType="pubmed">12719592</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao RY, et al. 2010. Identification of influenza A nucleoprotein as an antiviral target. Nat. Biotechnol. 28: 600&#x2013;605</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097325</ArticleId><ArticleId IdType="pubmed">20512121</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami E, et al. 2011. Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA. J. Virol. Methods 173: 1&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3049850</ArticleId><ArticleId IdType="pubmed">21185869</ArticleId></ArticleIdList></Reference><Reference><Citation>Layne SP, Monto AS, Taubenberger JK. 2009. Pandemic influenza: an inconvenient mutation. Science 323: 1560&#x2013;1561</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2778479</ArticleId><ArticleId IdType="pubmed">19299601</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ML, Ramirez BC, Krug RM. 1998. RNA-dependent activation of primer RNA production by influenza virus polymerase: different regions of the same protein subunit constitute the two required RNA-binding sites. EMBO J. 17: 5844&#x2013;5852</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1170912</ArticleId><ArticleId IdType="pubmed">9755184</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ML, Rao P, Krug RM. 2001. The active sites of the influenza cap-dependent endonuclease are on different polymerase subunits. EMBO J. 20: 2078&#x2013;2086</Citation><ArticleIdList><ArticleId IdType="pmc">PMC125234</ArticleId><ArticleId IdType="pubmed">11296240</ArticleId></ArticleIdList></Reference><Reference><Citation>Medcalf L, Poole E, Elton D, Digard P. 1999. Temperature-sensitive lesions in two influenza A viruses defective for replicative transcription disrupt RNA binding by the nucleoprotein. J. Virol. 73: 7349&#x2013;7356</Citation><ArticleIdList><ArticleId IdType="pmc">PMC104261</ArticleId><ArticleId IdType="pubmed">10438824</ArticleId></ArticleIdList></Reference><Reference><Citation>Mena I, et al. 1999. Mutational analysis of influenza A virus nucleoprotein: identification of mutations that affect RNA replication. J. Virol. 73: 1186&#x2013;1194</Citation><ArticleIdList><ArticleId IdType="pmc">PMC103939</ArticleId><ArticleId IdType="pubmed">9882320</ArticleId></ArticleIdList></Reference><Reference><Citation>Momose F, et al. 2002. Identification of Hsp90 as a stimulatory host factor involved in influenza virus RNA synthesis. J. Biol. Chem. 277: 45306&#x2013;45314</Citation><ArticleIdList><ArticleId IdType="pubmed">12226087</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullin AE, Dalton RM, Amorim MJ, Elton D, Digard P. 2004. Increased amounts of the influenza virus nucleoprotein do not promote higher levels of viral genome replication. J. Gen. Virol. 85: 3689&#x2013;3698</Citation><ArticleIdList><ArticleId IdType="pubmed">15557242</ArticleId></ArticleIdList></Reference><Reference><Citation>Naito T, Momose F, Kawaguchi A, Nagata K. 2007. Involvement of Hsp90 in assembly and nuclear import of influenza virus RNA polymerase subunits. J. Virol. 81: 1339&#x2013;1349</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1797515</ArticleId><ArticleId IdType="pubmed">17121807</ArticleId></ArticleIdList></Reference><Reference><Citation>Newcomb LL, et al. 2009. Interaction of the influenza A virus nucleocapsid protein with the viral RNA polymerase potentiates unprimed viral RNA replication. J. Virol. 83: 29&#x2013;36</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2612335</ArticleId><ArticleId IdType="pubmed">18945782</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto H, et al. 2000. Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37. Virology 272: 402&#x2013;408</Citation><ArticleIdList><ArticleId IdType="pubmed">10873784</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozawa M, et al. 2007. Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication. J. Virol. 81: 30&#x2013;41</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1797272</ArticleId><ArticleId IdType="pubmed">17050598</ArticleId></ArticleIdList></Reference><Reference><Citation>Palese P, Shaw ML. 2007. Orthomyxoviridae: the viruses and their replication, p 1647&#x2013;1689 In Knipe D. M., Howley P. M. (ed), Fields virology, 5th ed, vol. 2 Lippincott Williams &amp; Wilkins, Philadelphia, PA</Citation></Reference><Reference><Citation>Perez JT, et al. 2010. Influenza A virus-generated small RNAs regulate the switch from transcription to replication. Proc. Natl. Acad. Sci. U. S. A. 107: 11525&#x2013;11530</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2895093</ArticleId><ArticleId IdType="pubmed">20534471</ArticleId></ArticleIdList></Reference><Reference><Citation>Plotch SJ, Bouloy M, Ulmanen I, Krug RM. 1981. A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell 23: 847&#x2013;858</Citation><ArticleIdList><ArticleId IdType="pubmed">6261960</ArticleId></ArticleIdList></Reference><Reference><Citation>Portela A, Digard P. 2002. The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. J. Gen. Virol. 83: 723&#x2013;734</Citation><ArticleIdList><ArticleId IdType="pubmed">11907320</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter JR, Fritz CC, Depew KM. 2010. Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy. Curr. Opin. Chem. Biol. 14: 412&#x2013;420</Citation><ArticleIdList><ArticleId IdType="pubmed">20409745</ArticleId></ArticleIdList></Reference><Reference><Citation>Robb NC, Smith M, Vreede FT, Fodor E. 2009. NS2/NEP protein regulates transcription and replication of the influenza virus RNA genome. J. Gen. Virol. 90: 1398&#x2013;1407</Citation><ArticleIdList><ArticleId IdType="pubmed">19264657</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruigrok RW, Crepin T, Hart DJ, Cusack S. 2010. Towards an atomic resolution understanding of the influenza virus replication machinery. Curr. Opin. Struct. Biol. 20: 104&#x2013;113</Citation><ArticleIdList><ArticleId IdType="pubmed">20061134</ArticleId></ArticleIdList></Reference><Reference><Citation>Schonborn J, et al. 1991. Monoclonal antibodies to double-stranded RNA as probes of RNA structure in crude nucleic acid extracts. Nucleic Acids Res. 19: 2993&#x2013;3000</Citation><ArticleIdList><ArticleId IdType="pmc">PMC328262</ArticleId><ArticleId IdType="pubmed">2057357</ArticleId></ArticleIdList></Reference><Reference><Citation>Scull MA, Rice CM. 2010. A big role for small RNAs in influenza virus replication. Proc. Natl. Acad. Sci. U. S. A. 107: 11153&#x2013;11154</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2895133</ArticleId><ArticleId IdType="pubmed">20547839</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih SR, et al. 2010. Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity. J. Biomed. Sci. 17: 13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2838761</ArticleId><ArticleId IdType="pubmed">20178582</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih SR, et al. 2010. BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses. J. Antimicrob. Chemother. 65: 63&#x2013;71</Citation><ArticleIdList><ArticleId IdType="pubmed">19892833</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomassini JE, et al. 1996. A novel antiviral agent which inhibits the endonuclease of influenza viruses. Antimicrob. Agents Chemother. 40: 1189&#x2013;1193</Citation><ArticleIdList><ArticleId IdType="pmc">PMC163289</ArticleId><ArticleId IdType="pubmed">8723464</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulmanen I, Broni BA, Krug RM. 1981. Role of two of the influenza virus core P proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in initiating viral RNA transcription. Proc. Natl. Acad. Sci. U. S. A. 78: 7355&#x2013;7359</Citation><ArticleIdList><ArticleId IdType="pmc">PMC349265</ArticleId><ArticleId IdType="pubmed">6950380</ArticleId></ArticleIdList></Reference><Reference><Citation>Vreede FT, Jung TE, Brownlee GG. 2004. Model suggesting that replication of influenza virus is regulated by stabilization of replicative intermediates. J. Virol. 78: 9568&#x2013;9572</Citation><ArticleIdList><ArticleId IdType="pmc">PMC506943</ArticleId><ArticleId IdType="pubmed">15308750</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe T, Watanabe S, Kawaoka Y. 2010. Cellular networks involved in the influenza virus life cycle. Cell Host Microbe 7: 427&#x2013;439</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3167038</ArticleId><ArticleId IdType="pubmed">20542247</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber F, Wagner V, Rasmussen SB, Hartmann R, Paludan SR. 2006. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80: 5059&#x2013;5064</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1472073</ArticleId><ArticleId IdType="pubmed">16641297</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster RG, Govorkova EA. 2006. H5N1 influenza&#x2014;continuing evolution and spread. N. Engl. J. Med. 355: 2174&#x2013;2177</Citation><ArticleIdList><ArticleId IdType="pubmed">17124014</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise HM, et al. 2009. A complicated message: identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J. Virol. 83: 8021&#x2013;8031</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2715786</ArticleId><ArticleId IdType="pubmed">19494001</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong WR, Chen YY, Yang SM, Chen YL, Horng JT. 2005. Phosphorylation of PI3K/Akt and MAPK/ERK in an early entry step of enterovirus 71. Life Sci. 78: 82&#x2013;90</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094582</ArticleId><ArticleId IdType="pubmed">16150462</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh JY, et al. 2010. Anti-influenza drug discovery: structure-activity relationship and mechanistic insight into novel angelicin derivatives. J. Med. Chem. 53: 1519&#x2013;1533</Citation><ArticleIdList><ArticleId IdType="pubmed">20092255</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan P, et al. 2009. Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site. Nature 458: 909&#x2013;913</Citation><ArticleIdList><ArticleId IdType="pubmed">19194458</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>